HempFusion Wellness Inc. To Report First Quarter 2021 Earnings and Host Conference Call on May 17, 2021
HempFusion Wellness Inc (US:CBDHF) will report its financial results for Q1 2021 on May 17, 2021, at 4 p.m. ET, followed by a conference call at 4:15 p.m. ET. The company distributes a range of CBD and probiotic products across approximately 4,000 retail locations in the U.S. and internationally. HempFusion boasts a diverse product portfolio with 48 SKUs and aims to further expand with an additional 30 products in development. The announcement highlights the company's focus on regulatory compliance and human safety in the CBD market.
- Scheduled financial results report for Q1 2021 may provide insights into performance.
- Diverse product portfolio with 48 SKUs shows strong market presence.
- Plans for additional 30 products under development indicate growth potential.
- None.
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, announced today it will report its financial results for the first quarter ended March 31, 2021 at 4 p.m., Eastern Time, on Monday, May 17, 2021 followed by a 4:15 p.m., Eastern Time conference call and webcast with a question-and-answer session.
To participate in the call, please dial 888-506-0062. For international callers, dial 973-528-0011. Use Participant Code: 795055
To join the webcast: https://www.webcaster4.com/Webcast/Page/2710/41342
A replay will be available from the Investor Relations section of HempFusion’s website at HempFusion.com/corporate-information.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and Probulin on Twitter, Facebook and Instagram.
Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210511006231/en/
FAQ
When will HempFusion report its financial results for Q1 2021?
What is the stock symbol for HempFusion?
How can I participate in the HempFusion conference call?
What products does HempFusion offer?
Where can I find more information about HempFusion?
